vs
Side-by-side financial comparison of Genius Sports Ltd (GENI) and HUTCHMED (China) Ltd (HCM). Click either name above to swap in a different company.
Genius Sports Ltd is the larger business by last-quarter revenue ($510.9M vs $270.8M, roughly 1.9× HUTCHMED (China) Ltd). HUTCHMED (China) Ltd runs the higher net margin — 0.7% vs -12.3%, a 13.1% gap on every dollar of revenue. Genius Sports Ltd produced more free cash flow last quarter ($69.6M vs $3.4M).
Genius Sports is a sports data and technology company that provides data management, video streaming and integrity services to sports leagues, bookmakers and media companies.
HUTCHMED (China) LtdHCMEarnings & Financial Report
HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.
GENI vs HCM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $510.9M | $270.8M |
| Net Profit | $-63.0M | $2.0M |
| Gross Margin | 25.2% | 37.7% |
| Operating Margin | -11.5% | -13.2% |
| Net Margin | -12.3% | 0.7% |
| Revenue YoY | — | -16.5% |
| Net Profit YoY | — | -83.6% |
| EPS (diluted) | — | $0.00 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $510.9M | $270.8M | ||
| Q3 25 | $335.4M | — | ||
| Q2 25 | $215.2M | $277.7M | ||
| Q1 25 | $119.7M | $324.5M | ||
| Q4 24 | $413.0M | — | ||
| Q3 24 | $285.8M | — | ||
| Q2 24 | $184.1M | $305.7M | ||
| Q1 24 | $97.2M | — |
| Q4 25 | $-63.0M | $2.0M | ||
| Q3 25 | — | — | ||
| Q2 25 | $-47.3M | $455.0M | ||
| Q1 25 | $-25.5M | $11.9M | ||
| Q4 24 | $-85.5M | — | ||
| Q3 24 | $-47.1M | — | ||
| Q2 24 | $-35.5M | $25.8M | ||
| Q1 24 | $-25.2M | — |
| Q4 25 | 25.2% | 37.7% | ||
| Q3 25 | 24.2% | — | ||
| Q2 25 | 19.1% | 0.1% | ||
| Q1 25 | 10.7% | 48.0% | ||
| Q4 24 | 16.7% | — | ||
| Q3 24 | 20.5% | — | ||
| Q2 24 | 18.6% | 41.1% | ||
| Q1 24 | 9.8% | — |
| Q4 25 | -11.5% | -13.2% | ||
| Q3 25 | -15.3% | — | ||
| Q2 25 | -21.0% | -1.3% | ||
| Q1 25 | -20.3% | -5.0% | ||
| Q4 24 | -18.0% | — | ||
| Q3 24 | -13.9% | — | ||
| Q2 24 | -16.8% | -9.0% | ||
| Q1 24 | -23.7% | — |
| Q4 25 | -12.3% | 0.7% | ||
| Q3 25 | — | — | ||
| Q2 25 | -22.0% | 163.8% | ||
| Q1 25 | -21.3% | 3.7% | ||
| Q4 24 | -20.7% | — | ||
| Q3 24 | -16.5% | — | ||
| Q2 24 | -19.3% | 8.4% | ||
| Q1 24 | -25.9% | — |
| Q4 25 | — | $0.00 | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $0.52 | ||
| Q1 25 | — | $0.01 | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $0.03 | ||
| Q1 24 | — | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $280.6M | $1.4B |
| Total DebtLower is stronger | — | $93.2M |
| Stockholders' EquityBook value | $724.5M | $1.2B |
| Total Assets | $1.1B | $1.8B |
| Debt / EquityLower = less leverage | — | 0.08× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $280.6M | $1.4B | ||
| Q3 25 | $110.2M | — | ||
| Q2 25 | $110.2M | $1.4B | ||
| Q1 25 | $110.2M | $836.1M | ||
| Q4 24 | $100.3M | — | ||
| Q3 24 | $100.3M | — | ||
| Q2 24 | $100.3M | $802.5M | ||
| Q1 24 | $100.3M | — |
| Q4 25 | — | $93.2M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $93.4M | ||
| Q1 25 | — | $82.8M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $82.1M | ||
| Q1 24 | — | — |
| Q4 25 | $724.5M | $1.2B | ||
| Q3 25 | $572.4M | — | ||
| Q2 25 | $572.4M | $1.2B | ||
| Q1 25 | $572.4M | $759.9M | ||
| Q4 24 | $573.0M | — | ||
| Q3 24 | $573.0M | — | ||
| Q2 24 | $573.0M | $740.1M | ||
| Q1 24 | $573.0M | — |
| Q4 25 | $1.1B | $1.8B | ||
| Q3 25 | $792.3M | — | ||
| Q2 25 | $792.3M | $1.8B | ||
| Q1 25 | $792.3M | $1.3B | ||
| Q4 24 | $775.7M | — | ||
| Q3 24 | $775.7M | — | ||
| Q2 24 | $775.7M | $1.3B | ||
| Q1 24 | $775.7M | — |
| Q4 25 | — | 0.08× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.08× | ||
| Q1 25 | — | 0.11× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.11× | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $81.9M | $8.2M |
| Free Cash FlowOCF − Capex | $69.6M | $3.4M |
| FCF MarginFCF / Revenue | 13.6% | 1.2% |
| Capex IntensityCapex / Revenue | 2.4% | 1.8% |
| Cash ConversionOCF / Net Profit | — | 4.21× |
| TTM Free Cash FlowTrailing 4 quarters | $33.5M | $-96.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $81.9M | $8.2M | ||
| Q3 25 | $-4.8M | — | ||
| Q2 25 | $-1.2M | $-72.9M | ||
| Q1 25 | $-14.6M | $40.3M | ||
| Q4 24 | $14.9M | — | ||
| Q3 24 | $-9.2M | — | ||
| Q2 24 | — | $-39.8M | ||
| Q1 24 | — | — |
| Q4 25 | $69.6M | $3.4M | ||
| Q3 25 | $-14.2M | — | ||
| Q2 25 | $-5.8M | $-82.2M | ||
| Q1 25 | $-16.0M | $32.5M | ||
| Q4 24 | $11.3M | — | ||
| Q3 24 | $-11.6M | — | ||
| Q2 24 | — | $-49.9M | ||
| Q1 24 | — | — |
| Q4 25 | 13.6% | 1.2% | ||
| Q3 25 | -4.2% | — | ||
| Q2 25 | -2.7% | -29.6% | ||
| Q1 25 | -13.4% | 10.0% | ||
| Q4 24 | 2.7% | — | ||
| Q3 24 | -4.1% | — | ||
| Q2 24 | — | -16.3% | ||
| Q1 24 | — | — |
| Q4 25 | 2.4% | 1.8% | ||
| Q3 25 | 2.8% | — | ||
| Q2 25 | 2.1% | 3.3% | ||
| Q1 25 | 1.2% | 2.4% | ||
| Q4 24 | 0.9% | — | ||
| Q3 24 | 0.9% | — | ||
| Q2 24 | — | 3.3% | ||
| Q1 24 | — | — |
| Q4 25 | — | 4.21× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -0.16× | ||
| Q1 25 | — | 3.38× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -1.54× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
